Results for tag: "Tirofiban"

Tirofiban is a cardiovascular drug used to treat acute coronary syndrome (ACS). It is a glycoprotein IIb/IIIa inhibitor, which works by blocking the action of platelets in the blood, preventing them from forming clots. Tirofiban is administered intravenously and is used in combination with other drugs to reduce the risk of death and heart attack in patients with ACS. It is also used to reduce the risk of stroke in patients with non-ST-segment elevation myocardial infarction (NSTEMI). Tirofiban is available in both generic and branded forms, and is marketed by several pharmaceutical companies. Some of the companies in the market include Merck, Sanofi, Pfizer, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more